Could a single gene therapy injection slow Alzheimer's?
Disease control
Recruiting now
This early-stage study tests a gene therapy that delivers a protein called BDNF directly into the brain. The goal is to see if it is safe and can slow or prevent brain cell loss in people with early Alzheimer's disease or mild cognitive impairment. The study involves 12 participa…
Phase: PHASE1 • Sponsor: Mark Tuszynski • Aim: Disease control
Last updated May 04, 2026 16:21 UTC